Literature DB >> 24074804

Cortisol and depression in pre-diagnosed and early stage Huntington's disease.

Christopher A Shirbin1, Phyllis Chua, Andrew Churchyard, Georgia Lowndes, Anthony J Hannan, Terence Y Pang, Edmond Chiu, Julie C Stout.   

Abstract

Hypothalamic-pituitary-adrenal (HPA) axis dysfunction and depression have both been shown to occur in Huntington's disease (HD) gene carriers prior to diagnosis (pre-HD) and in diagnosed HD patients. However, the relationship between HPA axis dysfunction and the severity of depressive symptomatology in pre-HD and early-HD has not been systematically examined, despite morning hypercortisolism being a characteristic feature of some subtypes of idiopathic depression. The aim of this study was to investigate whether HPA axis function is related to levels of depression in pre-HD and early-HD. To assess HPA axis function we obtained salivary cortisol concentrations from 20 controls, 20 pre-HD, and 17 early-HD participants at four time points over a 24h period. Depression symptoms were assessed using the Inventory of Depressive Symptomatology - Self-Report. Of the participants who were found not to be depressed, the early-HD group had significantly lower morning cortisol levels relative to pre-HD and controls. In contrast, the early-HD group with at least mild or greater levels of depression symptoms had a comparable cortisol concentration to pre-HD and controls. The results suggest that early-HD may be associated with hypocortisolism. However when depressed, a hyperactive HPA axis response may still be induced in early-HD and lead to cortisol levels that are similar to pre-HD and controls. Our study reveals that cortisol levels in HD may be modified by the presence or absence of depressive symptomatology. Depression may be an important factor for understanding how the HPA axis is affected in HD, particularly in the morning.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cortisol; Depression; Huntington's disease; Hypothalamic-pituitary-adrenal axis; Saliva; Stress

Mesh:

Substances:

Year:  2013        PMID: 24074804     DOI: 10.1016/j.psyneuen.2012.10.020

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  14 in total

Review 1.  'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

Authors:  Aleksandar Videnovic; Alpar S Lazar; Roger A Barker; Sebastiaan Overeem
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

2.  A systems approach identifies networks and genes linking sleep and stress: implications for neuropsychiatric disorders.

Authors:  Peng Jiang; Joseph R Scarpa; Karrie Fitzpatrick; Bojan Losic; Vance D Gao; Ke Hao; Keith C Summa; He S Yang; Bin Zhang; Ravi Allada; Martha H Vitaterna; Fred W Turek; Andrew Kasarskis
Journal:  Cell Rep       Date:  2015-04-23       Impact factor: 9.423

Review 3.  Circadian rhythms in neurodegenerative disorders.

Authors:  Malik Nassan; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2021-11-10       Impact factor: 42.937

4.  Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.

Authors:  Brett D Dufour; Jodi L McBride
Journal:  Neurobiol Dis       Date:  2018-10-05       Impact factor: 5.996

5.  Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease.

Authors:  Brett D Dufour; Jodi L McBride
Journal:  Exp Neurol       Date:  2016-07-02       Impact factor: 5.330

Review 6.  Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

Authors:  Xin Du; Terence Y Pang
Journal:  Front Psychiatry       Date:  2015-03-09       Impact factor: 4.157

Review 7.  Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms.

Authors:  Patrick Pla; Sophie Orvoen; Frédéric Saudou; Denis J David; Sandrine Humbert
Journal:  Front Behav Neurosci       Date:  2014-04-23       Impact factor: 3.558

8.  Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's Disease.

Authors:  Dika A Kuljis; Laura Gad; Dawn H Loh; Zoë MacDowell Kaswan; Olivia N Hitchcock; Cristina A Ghiani; Christopher S Colwell
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

Review 9.  Huntingtin gene repeat size variations affect risk of lifetime depression.

Authors:  Sarah L Gardiner; Martine J van Belzen; Merel W Boogaard; Willeke M C van Roon-Mom; Maarten P Rozing; Albert M van Hemert; Johannes H Smit; Aartjan T F Beekman; Gerard van Grootheest; Robert A Schoevers; Richard C Oude Voshaar; Raymund A C Roos; Hannie C Comijs; Brenda W J H Penninx; Roos C van der Mast; N Ahmad Aziz
Journal:  Transl Psychiatry       Date:  2017-12-11       Impact factor: 6.222

Review 10.  A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.

Authors:  Edina Silajdžić; Maria Björkqvist
Journal:  J Huntingtons Dis       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.